Debt-to-equity of Unity Biotechnology, Inc. from 30 Sep 2018 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Unity Biotechnology, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 31 Mar 2025.
  • Unity Biotechnology, Inc. Debt-to-equity for the quarter ending 31 Mar 2025 was 320%, a 122% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Unity Biotechnology, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2025 320% +176% +122% 31 Mar 2025
Q4 2024 206% +73% +55% 31 Dec 2024
Q3 2024 161% +31% +24% 30 Sep 2024
Q2 2024 148% +22% +18% 30 Jun 2024
Q1 2024 144% +19% +16% 31 Mar 2024
Q4 2023 133% +7% +5.2% 31 Dec 2023
Q3 2023 130% +7% +5.5% 30 Sep 2023
Q2 2023 125% +4% +3.1% 30 Jun 2023
Q1 2023 125% +11% +9.8% 31 Mar 2023
Q4 2022 127% +23% +23% 31 Dec 2022
Q3 2022 123% +25% +26% 30 Sep 2022
Q2 2022 121% +33% +37% 30 Jun 2022
Q1 2022 113% +41% +56% 31 Mar 2022
Q4 2021 103% +39% +61% 31 Dec 2021
Q3 2021 98% +49% +101% 30 Sep 2021
Q2 2021 88% +53% +147% 30 Jun 2021
Q1 2021 73% +43% +148% 31 Mar 2021
Q4 2020 64% +45% +230% 31 Dec 2020
Q3 2020 49% +32% +200% 30 Sep 2020
Q2 2020 36% +23% +185% 30 Jun 2020
Q1 2020 29% +20% +215% 31 Mar 2020
Q4 2019 19% +5% +34% 31 Dec 2019
Q3 2019 16% -12% -42% 30 Sep 2019
Q2 2019 13% 30 Jun 2019
Q1 2019 9% 31 Mar 2019
Q4 2018 14% 31 Dec 2018
Q3 2018 28% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.